Advertisement

Decision-Making Dysfunctions in Psychiatry—Altered Homeostatic Processing?

Science26 Oct 2007Vol 318, Issue 5850pp. 602-606DOI: 10.1126/science.1142997

Abstract

Decision-making consists of selecting an action from a set of available options. This results in an outcome that changes the state of the decision-maker. Therefore, decision-making is part of a homeostatic process. Individuals with psychiatric disorders show altered decision-making. They select options that are either non-optimal or nonhomeostatic. These dysfunctional patterns of decision-making in individuals with psychiatric disorders may fundamentally relate to problems with homeostatic regulation. These may manifest themselves in (i) how the length of time between decisions and their outcomes influences subsequent decision-making, (ii) how gain and loss feedback are integrated to determine the optimal decision, (iii) how individuals adapt their decision strategies to match the specific context, or (iv) how seemingly maladaptive responses result from an attempt to establish an unstable homeostatic balance.
Get full access to this article

View all available purchase options and get full access to this article.

Already a Subscriber?

References and Notes

1
A. D. Craig, Nat. Rev. Neurosci.3, 655 (2002).
2
M. Ernst, M. P. Paulus, Biol. Psychiatry58, 597 (2005).
3
D. Kahneman, A. Tversky, Am. Psychol.39, 341 (1984).
4
P. R. Montague, B. King-Casas, J. D. Cohen, Annu. Rev. Neurosci.29, 417 (2006).
5
J. Von Neumann, O. Morgenstern, Theory of Games and Economic Behavior (Princeton Univ. Press, Princeton, NJ, ed. 2, 1947).
6
D. Kahneman, A. Tversky, Econometrica47, 263 (1979).
7
P. Slovic, Am. Psychol.50, 364 (1995).
8
G. Loewenstein, Organ. Behav. Hum. Decis. Process.65, 272 (1996).
9
Y. Rottenstreich, C. K. Hsee, Psychol. Sci.12, 185 (2001).
10
H. C. Breiter, I. Aharon, D. Kahneman, A. Dale, P. Shizgal, Neuron30, 619 (2001).
11
B. Knutson, J. Taylor, M. Kaufman, R. Peterson, G. Glover, J. Neurosci.25, 4806 (2005).
12
M. L. Platt, P. W. Glimcher, Nature400, 233 (1999).
13
W. Schultz, Annu. Rev. Psychol.57, 87 (2006).
14
J. I. Gold, M. N. Shadlen, Trends Cognit. Sci.5, 10 (2001).
15
A. R. Damasio, Sci. Am.271, 144 (1994).
16
A. Bechara, H. Damasio, D. Tranel, A. R. Damasio, Science275, 1293 (1997).
17
A. Bechara, H. Damasio, A. R. Damasio, Cereb. Cortex10, 295 (2000).
18
A. D. (Bud) Craig, Trends Neurosci.26, 303 (2003).
19
N. D. Daw, J. P. O'Doherty, P. Dayan, B. Seymour, R. J. Dolan, Nature441, 876 (2006).
20
B. De Martino, D. Kumaran, B. Seymour, R. J. Dolan, Science313, 684 (2006).
21
G. F. Koob, M. Le Moal, Science278, 52 (1997).
22
M. Bateson, Proc. Nutr. Soc.61, 509 (2002).
23
C. J. Pietras, T. D. Hackenberc, J. Exp. Anal. Behav.76, 1 (2001).
24
G. Dom, B. Sabbe, W. Hulstijn, B. W. van den Brink, Br. J. Psychiatry187, 209 (2005).
25
G. J. Madden, W. K. Bickel, E. A. Jacobs, Exp. Clin. Psychopharmacol.7, 284 (1999).
26
S. F. Coffey, G. D. Gudleski, M. E. Saladin, K. T. Brady, Exp. Clin. Psychopharmacol.11, 18 (2003).
27
N. M. Petry, T. Casarella, Drug Alcohol Depend.56, 25 (1999).
28
N. M. Petry, Psychopharmacology (Berlin)162, 425 (2002).
29
G. Ainslie, in Picoeconomics: The Strategic Interaction of Successive Motivational States Within the Person (Cambridge Univ. Press, New York, 1992), pp. 56–95.
30
K. N. Kirby, N. M. Petry, W. K. Bickel, J. Exp. Psychol. Gen.128, 78 (1999).
31
S. H. Kollins, Addict. Behav.28, 1167 (2003).
32
S. Grant, C. Contoreggi, E. D. London, Neuropsychologia38, 1180 (2000).
33
R. Gonzalez, A. Bechara, E. M. Martin, J. Clin. Exp. Neuropsychol.29, 155 (2007).
34
A. Verdejo-Garcia, R. Vilar-Lopez, M. Perez-Garcia, K. Podell, E. Goldberg, J. Int. Neuropsychol. Soc.12, 90 (2006).
35
A. Verdejo-Garcia, C. Rivas-Perez, R. Vilar-Lopez, M. Perez-Garcia, Drug Alcohol Depend.86, 139 (2007).
36
B. B. Quednowet al., Psychopharmacology (Berlin)189, 517 (2007).
37
G. Dom, B. De Wilde, W. Hulstijn, B. W. van den Brink, B. Sabbe, Alcohol. Clin. Exp. Res.30, 1670 (2006).
38
R. Pirastuet al., Drug Alcohol Depend.83, 163 (2006).
39
A. Becharaet al., Neuropsychologia39, 376 (2001).
40
R. D. Rogerset al., Neuropsychopharmacology20, 322 (1999).
41
M. P. Paulus, N. Hozack, L. Frank, G. G. Brown, M. A. Schuckit, Biol. Psychiatry53, 65 (2003).
42
J. Monterosso, R. Ehrman, K. L. Napier, C. P. O'Brien, A. R. Childress, Addiction96, 1825 (2001).
43
J. R. Monterossoet al., Hum. Brain Mapp.28, 383 (2007).
44
M. P. Pauluset al., Neuropsychopharmacology26, 53 (2002).
45
K. I. Bollaet al., Neuroimage19, 1085 (2003).
46
A. Bechara, Nat. Neurosci.8, 1458 (2005).
47
J. McCartney, Subst. Use Misuse32, 2061 (1997).
48
D. R. Cherek, S. D. Lane, Psychopharmacology (Berlin)157, 221 (2001).
49
D. S. Leland, M. P. Paulus, Drug Alcohol Depend.78, 83 (2005).
50
D. S. Leland, E. Arce, J. S. Feinstein, M. P. Paulus, Neuroimage33, 725 (2006).
51
S. Rahmanet al., Neuropsychopharmacology31, 651 (2006).
52
C. N. Ortner, T. K. MacDonald, M. C. Olmstead, Alcohol Alcohol.38, 151 (2003).
53
J. B. Richards, L. Zhang, S. H. Mitchell, H. de Wit, J. Exp. Anal. Behav.71, 121 (1999).
54
H. de Wit, J. L. Enggasser, J. B. Richards, Neuropsychopharmacology27, 813 (2002).
55
F. X. Vollenweider, M. E. Liechti, M. P. Paulus, J. Psychopharmacol.19, 366 (2005).
56
B. Reynolds, J. B. Richards, M. Dassinger, H. de Wit, Pharmacol. Biochem. Behav.79, 17 (2004).
57
J. McDonald, L. Schleifer, J. B. Richards, H. de Wit, Neuropsychopharmacology28, 1356 (2003).
58
S. D. Lane, D. R. Cherek, O. V. Tcheremissine, L. M. Lieving, C. J. Pietras, Neuropsychopharmacology30, 800 (2005).
59
S. D. Lane, O. V. Tcheremissine, L. M. Lieving, S. Nouvion, D. R. Cherek, Psychopharmacology (Berlin)181, 364 (2005).
60
J. Epsteinet al., Am. J. Psychiatry163, 1784 (2006).
61
E. E. Forbeset al., J. Child Psychol. Psychiatry47, 1031 (2006).
62
A. Mustet al., J. Affect. Disord.90, 209 (2006).
63
T. Christodoulou, M. Lewis, G. B. Ploubidis, S. Frangou, Eur. Psychiatry21, 270 (2006).
64
F. C. Murphyet al., Psychol. Med.31, 679 (2001).
65
A. Minassian, M. P. Paulus, W. Perry, J. Affect. Disord.82, 203 (2004).
66
R. Ladouceur, P. Gosselin, M. J. Dugas, Behav. Res. Ther.38, 933 (2000).
67
I. Blanchette, A. Richards, J. Exp. Psychol. Gen.132, 294 (2003).
68
M. P. Paulus, J. S. Feinstein, A. Simmons, M. B. Stein, Biol. Psychiatry55, 1179 (2004).
69
A. L. Krainet al., J. Child Psychol. Psychiatry47, 1023 (2006).
70
S. Reiss, R. A. Peterson, D. M. Gursky, R. J. McNally, Behav. Res. Ther.24, 1 (1986).
71
M. P. Paulus, M. B. Stein, Biol. Psychiatry60, 383 (2006).
72
A. Simmons, S. C. Matthews, M. B. Stein, M. P. Paulus, Neuroreport15, 2261 (2004).
73
M. P. Paulus, C. Rogalsky, A. Simmons, J. S. Feinstein, M. B. Stein, Neuroimage19, 1439 (2003).
74
P. L. Remijnseet al., Arch. Gen. Psychiatry63, 1225 (2006).
75
N. S. Lawrenceet al., Neuropsychology20, 409 (2006).
76
M. M. Nielen, D. J. Veltman, R. de Jong, G. Mulder, J. A. den Boer, J. Affect. Disord.69, 257 (2002).
77
K. D. Fitzgeraldet al., Biol. Psychiatry57, 287 (2005).
78
P. S. Sachdev, G. S. Malhi, Aust. N. Z. J. Psychiatry39, 757 (2005).
79
O. H. Turnbull, C. E. Evans, K. Kemish, S. Park, C. H. Bowman, Neuropsychology20, 290 (2006).
80
S. B. Huttonet al., Schizophr. Res.55, 249 (2002).
81
M. P. Paulus, M. A. Geyer, D. L. Braff, Am. J. Psychiatry153, 714 (1996).
82
M. P. Paulus, M. A. Geyer, D. L. Braff, Schizophr. Res.35, 69 (1999).
83
M. P. Paulus, W. Perry, D. L. Braff, Biol. Psychiatry46, 662 (1999).
84
K. Ludewig, M. P. Paulus, F. X. Vollenweider, Psychiatry Res.119, 293 (2003).
85
M. P. Paulus, L. Frank, G. G. Brown, D. L. Braff, Neuropsychopharmacology28, 795 (2003).
86
S. Stroupet al., Schizophr. Res.80, 1 (2005).
87
A. D. Redish, Science306, 1944 (2004).
88
I would like to acknowledge the help of E. Arce, D. Leland, S. Matthews, M. Wittmann, and A. Simmons during the preparation of the manuscript. This research was supported by grants from the National Institute on Drug Abuse (R01DA016663 and R01DA018307) and a U.S. Department of Veterans Affairs merit grant.

Information & Authors

Information

Published In

Science
Volume 318 | Issue 5850
26 October 2007

Submission history

Published in print: 26 October 2007

Permissions

Request permissions for this article.

Authors

Affiliations

Martin P. Paulus
Department of Psychiatry, University of California at San Diego, 8950 Villa La Jolla Drive, La Jolla, CA 92037–0985, USA; and Veterans Affairs Health Care System San Diego, 3350 La Jolla Village Drive, San Diego, CA 92161, USA. E-mail: [email protected]

Metrics & Citations

Metrics

Article Usage
Altmetrics

Citations

Export citation

Select the format you want to export the citation of this publication.

Cited by
  1. The functional connectivity between the prefrontal cortex and supplementary motor area moderates the relationship between internet gaming disorder and loneliness, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 108, (110154), (2021).https://doi.org/10.1016/j.pnpbp.2020.110154
    Crossref
  2. How childhood ADHD-like symptoms predict selection into entrepreneurship and implications on entrepreneurial performance, Journal of Business Venturing, 36, 3, (106091), (2021).https://doi.org/10.1016/j.jbusvent.2021.106091
    Crossref
  3. Circuit selectivity in drug versus natural reward seeking behaviors, Journal of Neurochemistry, 157, 5, (1450-1472), (2021).https://doi.org/10.1111/jnc.15297
    Crossref
  4. Event-related brain response to visual cues in individuals with Internet gaming disorder: relevance to attentional bias and decision-making, Translational Psychiatry, 11, 1, (2021).https://doi.org/10.1038/s41398-021-01375-x
    Crossref
  5. The Influence of Substance Abuse on Inhibition Capacities and Risky Decision in a Group of Outpatient Schizophrenia Patients, Journal of Dual Diagnosis, 17, 2, (143-150), (2021).https://doi.org/10.1080/15504263.2021.1904164
    Crossref
  6. Interoception and alcohol: Mechanisms, networks, and implications, Neuropharmacology, 200, (108807), (2021).https://doi.org/10.1016/j.neuropharm.2021.108807
    Crossref
  7. The Rupture and Repair of Cooperation in Borderline Personality Disorder, Science, 321, 5890, (806-810), (2021)./doi/10.1126/science.1156902
    Abstract
  8. Trusting behavior and depressive symptoms, Nordic Psychology, (1-12), (2021).https://doi.org/10.1080/19012276.2021.1945948
    Crossref
  9. Trigeminal neuropathy causes hypomyelination in the anterior cingulate cortex, disrupts the synchrony of neural circuitry, and impairs decision‐making in male rats, Journal of Neuroscience Research, (2021).https://doi.org/10.1002/jnr.24903
    Crossref
  10. Risk-Based Decision Making: A Systematic Scoping Review of Animal Models and a Pilot Study on the Effects of Sleep Deprivation in Rats, Clocks & Sleep, 3, 1, (31-52), (2021).https://doi.org/10.3390/clockssleep3010003
    Crossref
  11. See more
Loading...

View Options

Get Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.
More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media